JBS forays into cell-based proteins


Global meat producer JBS is investing USD 100 million as it forays into cell-based proteins. The company will spend USD 41 million to acquire and expand Spain’s BioTech Foods’ commercial production facility in San Sebastian that is expected to be operational by 2024. It will also build an r&d s...

Sign in  as a member, or Join our Community  for free to unlock the full article.